CRSP Research and Charts

CRSP - CRISPR Therapeutics AG (Healthcare: Biotechnology)

Projected Earnings Date: 2025-11-02 (Delayed quote data 2025-09-12)

Last 56.26	Change ⇑ +0.37 (+0.66%)	Volume 1,996,936
	Open 56.10	High 56.47	Low 55.10

8EMA (Daily) 54.39	40EMA (Daily) 54.24	50EMA (Daily) 53.64	STO (Daily) 64.934	MACD Hist (Daily) 0.429
8EMA (Weekly) 55.037	40EMA (Weekly) 49.15	50EMA (Weekly) 49.07	STO (Weekly) 54.731	MACD Hist (Weekly) 0.537


Company Profile
CRISPR Therapeutics AG is a gene-editing company. It is engaged in the development of CRISPR/Cas9-based therapeutics. CRISPR/Cas9 is a technology that allows for precise, directed changes to genomic DNA. The company advanced programs target beta-thalassemia and sickle cell disease, two hemoglobinopathies that have a high unmet medical need.

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.